BBWI · Bath & Body Works, Inc.
Market Cap
$3.74B
Shares
201.65M
BBWI metrics
85 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$18.53
Market cap
$3.74B
Price action
19 metricsPrice change (1W)
+5.9%
Price change (30D)
-11.3%
Price change (3M)
-0.6%
Price change (6M)
-17.0%
Price change (YTD)
-7.3%
Price change (1Y)
-36.3%
Trailing year
Price change (5Y)
-71.9%
52-week high
$31.87
52-week low
$14.85
Change from 52-week high
-41.6%
Change from 52-week low
+25.3%
Annualized volatility
58.9%
Beta
1.4
RSI (14D)
44.6
Price vs SMA 50
-8.0%
Price vs SMA 200
-7.4%
Avg volume (3M)
5.77M
Relative volume
1.1
Average dollar volume
$114.78M
Company
3 metricsSector
Consumer Cyclical
Industry
Specialty Retail
Shares outstanding
201.65M
Valuation
12 metricsP / E (TTM)
4.9
Trailing earnings · reciprocal yield 20.4%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 185.7%
P / book
—
FCF yield
26.6%
TTM · current market cap
Buyback yield
3.8%
P / FCF
3.8
reciprocal yield 26.6%
P / operating cash flow
3.0
reciprocal yield 32.8%
Earnings yield
20.1%
Historical valuation
8 metricsP / E historical average (3Y)
8.4×
reciprocal yield 11.9%
P / E historical average (5Y)
9.0×
reciprocal yield 11.2%
EV / revenue historical average (3Y)
1.4×
reciprocal yield 73.1%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 66.6%
EV / EBIT historical average (3Y)
8.1×
reciprocal yield 12.4%
EV / EBIT historical average (5Y)
8.1×
reciprocal yield 12.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
4.3%
Trailing 12 months
Payout ratio
—
Shareholder yield
3.8%
Dividend / share (TTM)
$0.80
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-21
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-26
Profitability
9 metricsGross margin
44.1%
Operating margin
16.7%
Trailing 12 months
Net margin
10.8%
Gross profit (TTM)
$3.18B
Operating profit (TTM)
$1.21B
Net income (TTM)
$781.00M
Trailing 12 months
Diluted EPS (TTM)
$3.80
FCF margin
14.3%
Effective tax rate
19.6%
Growth
11 metricsRevenue growth YoY
-2.3%
Year over year
Net income growth YoY
+84.4%
Revenue (TTM)
$7.21B
Trailing 12 months
EPS growth YoY
+93.3%
Shares change YoY
-4.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.2%
Revenue CAGR (5Y)
+2.5%
EPS CAGR (3Y)
-3.2%
EPS CAGR (5Y)
+0.7%
FCF CAGR (3Y)
+2.0%
FCF CAGR (5Y)
-13.7%
Quality
14 metricsReturn on equity
—
Return on assets
15.1%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
$2.25B
Free cash flow (TTM)
$1.03B
Quick ratio
0.7
Interest coverage
4.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$794.00M
Total assets
$5.16B
Total debt
$3.61B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$1.27B
Capital expenditures (TTM)
$242.00M
R&D (TTM)
—
SG&A (TTM)
$1.98B
Stock compensation (TTM)
$23.00M
R&D / revenue
—
Stock compensation / revenue
0.3%
Ownership (13F)
3 metrics13F filers
474
13F filer change QoQ
0
Institutional ownership
105.1%
Short interest
3 metricsShort interest
7.0%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
60 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
701985
CUSIP
070830104
13F (30d)
339 filings
329 filers
Visit website
Investor relations